Presentation will be held on Monday, September 12, 2022, from 10:30 a.m. to 11:00 a.m. EDT NEW HAVEN, Conn., Sept. 7, 2022 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage...

GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the results from phase I study of GFH018 (TGF-β R1...

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will...

Preliminary Dose Escalation Data on ROS1-selective Inhibitor NVL-520 to be Presented in the "New Drugs on the Horizon" Oral Plenary Session New Preclinical Data to be Presented on Parallel-lead,...

Join Minelab Metal Detectors at their test beds at the UK metal detecting festival September 10 and 11. CAMBRIDGE, United Kingdom, Sept. 7, 2022 /PRNewswire/ -- In the UK's largest metal detecting...